{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:24:24Z","timestamp":1781796264398,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Chronic Kidney Disease (CKD) frequently leads to Mineral Bone Disorder (MBD), which significantly affects patient quality of life due to bone fragility and metabolic disturbances. This study investigates the role of Casein Kinase 2 (CK2) and Ubiquitin-Specific Protease 7 (USP7) in modulating Runt-related Transcription Factor 2 (RUNX2)-driven osteogenesis in a CKD-MBD mouse model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A CKD-MBD mouse model was established using 5\/6 nephrectomy. Bioinformatic analysis of CKD-related datasets identified RUNX2 and USP7 as key genes implicated in bone metabolism. In vivo and in vitro experiments were conducted to assess the effects of CK2-mediated phosphorylation and USP7-induced deubiquitination on RUNX2 stability and function. Histomorphometry, Enzyme-Linked Immunosorbent Assay (ELISA), and micro-CT analyses were performed to evaluate bone density, strength, and metabolic markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>RUNX2 and USP7 were significantly downregulated in CKD-MBD mice. Silencing RUNX2 impaired osteoblast differentiation, reduced bone density, and increased bone turnover, while CK2 overexpression restored RUNX2 activity by phosphorylation, recruiting USP7 to stabilize RUNX2. Enhanced osteoblast differentiation and improved bone metabolism were observed in CKD-MBD mice upon CK2 activation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>CK2 activation promotes RUNX2 phosphorylation and stabilization by USP7, leading to improved osteogenesis and bone metabolism in CKD-MBD. Targeting the CK2\/USP7\/RUNX2 axis presents a potential therapeutic strategy for managing CKD-related bone disorders.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10020-025-01222-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:13:56Z","timestamp":1748603636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting casein kinase 2 and ubiquitin-specific protease 7 to modulate RUNX2-mediated osteogenesis in chronic kidney disease"],"prefix":"10.1186","volume":"31","author":[{"given":"Haifeng","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"2\u20134","key":"1222_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000324763","volume":"194","author":"M Adhami","year":"2011","unstructured":"Adhami M, Ghori-Javed FY, Chen H, Gutierrez SE, Javed A. Runx2 regulates the gene network associated with insulin signaling and energy homeostasis. Cells Tissues Organs. 2011;194(2\u20134):232\u20137. https:\/\/doi.org\/10.1159\/000324763.","journal-title":"Cells Tissues Organs"},{"issue":"4","key":"1222_CR63","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jor.23342","volume":"35","author":"H Akkiraju","year":"2016","unstructured":"Akkiraju H, Bonor J, Nohe A. CK2.1, a novel peptide, induces articular cartilage formation in vivo. J Orthop Res. 2016;35(4):876\u201385. https:\/\/doi.org\/10.1002\/jor.23342.","journal-title":"J Orthop Res"},{"issue":"1","key":"1222_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.gendis.2020.10.004","volume":"9","author":"A Al-Eidan","year":"2022","unstructured":"Al-Eidan A, Wang Y, Skipp P, Ewing RM. The USP7 protein interaction network and its roles in tumorigenesis. Genes Dis. 2022;9(1):41\u201350. https:\/\/doi.org\/10.1016\/j.gendis.2020.10.004.","journal-title":"Genes Dis"},{"key":"1222_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2016.01.024","volume":"147","author":"J An","year":"2016","unstructured":"An J, Yang H, Zhang Q, et al. Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci. 2016;147:46\u201358. https:\/\/doi.org\/10.1016\/j.lfs.2016.01.024.","journal-title":"Life Sci"},{"issue":"10365","key":"1222_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/s0140-6736(22)02074-8","volume":"400","author":"C Baigent","year":"2022","unstructured":"Baigent C, Emberson JR, Haynes R, et al. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788\u2013801. https:\/\/doi.org\/10.1016\/s0140-6736(22)02074-8.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"1222_CR48","first-page":"S151","volume":"55","author":"KV Ba\u00f1uelos-Ch\u00e1vez","year":"2017","unstructured":"Ba\u00f1uelos-Ch\u00e1vez KV, Cerrillos-Guti\u00e9rrez JI, Nario JC, et al. Diagnosis and clinical implications of vascular calcification of chronic kidney disease in Mexico. Rev Med Inst Mex Seguro Soc. 2017;55(Suppl 2):S151\u20137.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"3","key":"1222_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40477-020-00477-4","volume":"23","author":"S Bianchi","year":"2020","unstructured":"Bianchi S. Ultrasound and bone: a pictorial review. J Ultrasound. 2020;23(3):227\u201357. https:\/\/doi.org\/10.1007\/s40477-020-00477-4.","journal-title":"J Ultrasound"},{"issue":"3","key":"1222_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","volume":"182","author":"M Bouhaddou","year":"2020","unstructured":"Bouhaddou M, Memon D, Meyer B, et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182(3):685\u2013e71219. https:\/\/doi.org\/10.1016\/j.cell.2020.06.034.","journal-title":"Cell"},{"issue":"15","key":"1222_CR49","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3390\/nu14153009","volume":"14","author":"V Brandenburg","year":"2022","unstructured":"Brandenburg V, Ketteler M, Vitamin D. Secondary hyperparathyroidism in chronic kidney disease: A critical appraisal of the past, present, and the future. Nutrients. 2022;14(15):3009. https:\/\/doi.org\/10.3390\/nu14153009.","journal-title":"Nutrients"},{"key":"1222_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.yjmcc.2023.03.011","volume":"179","author":"A Candellier","year":"2023","unstructured":"Candellier A, Issa N, Grissi M, et al. Indoxyl-sulfate activation of the AhR- NF-\u03baB pathway promotes interleukin-6 secretion and the subsequent osteogenic differentiation of human valvular interstitial cells from the aortic valve. J Mol Cell Cardiol. 2023;179:18\u201329. https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.011.","journal-title":"J Mol Cell Cardiol"},{"issue":"22","key":"1222_CR66","doi-asserted-by":"publisher","first-page":"35508","DOI":"10.18632\/oncotarget.16348","volume":"8","author":"G Carr\u00e0","year":"2017","unstructured":"Carr\u00e0 G, Panuzzo C, Torti D, et al. Therapeutic Inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated\/deleted clones. Oncotarget. 2017;8(22):35508\u201322. https:\/\/doi.org\/10.18632\/oncotarget.16348.","journal-title":"Oncotarget"},{"issue":"7\u20138","key":"1222_CR65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.lfs.2010.12.009","volume":"88","author":"WF Chiou","year":"2011","unstructured":"Chiou WF, Lee CH, Liao JF, Chen CC. 8-Prenylkaempferol accelerates osteoblast maturation through bone morphogenetic protein-2\/p38 pathway to activate Runx2 transcription. Life Sci. 2011;88(7\u20138):335\u201342. https:\/\/doi.org\/10.1016\/j.lfs.2010.12.009.","journal-title":"Life Sci"},{"issue":"2","key":"1222_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jbmr.4459","volume":"37","author":"HW Chiu","year":"2020","unstructured":"Chiu HW, Hou YC, Lu CL, et al. Cinacalcet improves bone parameters through regulation of osteoclast Endoplasmic reticulum stress, autophagy, and apoptotic pathways in chronic kidney Disease\u2013Mineral and bone disorder. J Bone Miner Res. 2020;37(2):215\u201325. https:\/\/doi.org\/10.1002\/jbmr.4459.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1222_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ndt\/gfaa203","volume":"36","author":"G Cianciolo","year":"2020","unstructured":"Cianciolo G, La Manna G, Capelli I, et al. The role of activin: the other side of chronic kidney disease\u2013mineral bone disorder? Nephrol Dialysis Transplantation. 2020;36(6):966\u201374. https:\/\/doi.org\/10.1093\/ndt\/gfaa203.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"3","key":"1222_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Cl\u00e9zardin","year":"2021","unstructured":"Cl\u00e9zardin P, Coleman R, Puppo M, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101(3):797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019.","journal-title":"Physiol Rev"},{"key":"1222_CR40","doi-asserted-by":"publisher","unstructured":"Dai G, Xiao H, Zhao C, Chen H, Liao J, Huang W. LncRNA H19 regulates BMP2-Induced hypertrophic differentiation of mesenchymal stem cells by promoting Runx2 phosphorylation. Front Cell Dev Biol. 2020;8. https:\/\/doi.org\/10.3389\/fcell.2020.00580.","DOI":"10.3389\/fcell.2020.00580"},{"issue":"8","key":"1222_CR8","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1681\/asn.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, et al. CKD-Induced Wingless\/Integration1 inhibitors and phosphorus cause the CKD\u2013Mineral and bone disorder. J Am Soc Nephrol. 2014;25(8):1760\u201373. https:\/\/doi.org\/10.1681\/asn.2013080818.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1222_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ndt\/gfr316","volume":"27","author":"ML Ford","year":"2011","unstructured":"Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Nephrol Dialysis Transplantation. 2011;27(2):727\u201333. https:\/\/doi.org\/10.1093\/ndt\/gfr316.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"10","key":"1222_CR71","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.3390\/ijms25105291","volume":"25","author":"AN Gargalionis","year":"2024","unstructured":"Gargalionis AN, Adamopoulos C, Vottis CT, Papavassiliou AG, Basdra EK. Runx2 and polycystins in bone mechanotransduction: challenges for therapeutic opportunities. IJMS. 2024;25(10):5291. https:\/\/doi.org\/10.3390\/ijms25105291.","journal-title":"IJMS"},{"key":"1222_CR28","doi-asserted-by":"publisher","unstructured":"gianni. MiR-137 affects bone mineral density in osteoporosis rats through regulating RUNX2. European review. Published Online Febr. 2020;13. https:\/\/doi.org\/10.26355\/eurrev_202002_20152.","DOI":"10.26355\/eurrev_202002_20152"},{"key":"1222_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/3641317","volume":"2021","author":"M Guan","year":"2021","unstructured":"Guan M, Pan D, Zhang M, Leng X, Yao B. The aqueous extract of Eucommia leaves promotes proliferation, differentiation, and mineralization of Osteoblast-Like MC3T3-E1 cells. Evidence-Based Complement Altern Med. 2021;2021:1\u201312. https:\/\/doi.org\/10.1155\/2021\/3641317.","journal-title":"Evidence-Based Complement Altern Med"},{"key":"1222_CR60","doi-asserted-by":"publisher","unstructured":"Guo Y, Wang M, Zhang S, et al. Ubiquitin-specific protease USP 34 controls osteogenic differentiation and bone formation by regulating BMP 2 signaling. EMBO J. 2018;37(20). https:\/\/doi.org\/10.15252\/embj.201899398.","DOI":"10.15252\/embj.201899398"},{"issue":"43","key":"1222_CR42","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1038\/onc.2011.177","volume":"30","author":"GE Hannigan","year":"2011","unstructured":"Hannigan GE, McDonald PC, Walsh MP, Dedhar S. Integrin-linked kinase: not so \u2018pseudo\u2019 after all. Oncogene. 2011;30(43):4375\u201385. https:\/\/doi.org\/10.1038\/onc.2011.177.","journal-title":"Oncogene"},{"key":"1222_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2016.02.006","volume":"86","author":"CM Heveran","year":"2016","unstructured":"Heveran CM, Ortega AM, Cureton A, et al. Moderate chronic kidney disease impairs bone quality in C57Bl\/6J mice. Bone. 2016;86:1\u20139. https:\/\/doi.org\/10.1016\/j.bone.2016.02.006.","journal-title":"Bone"},{"key":"1222_CR19","doi-asserted-by":"publisher","unstructured":"Hitz E, Gr\u00fcninger O, Passecker A, et al. The catalytic subunit of plasmodium falciparum casein kinase 2 is essential for gametocytogenesis. Commun Biol. 2021;4(1). https:\/\/doi.org\/10.1038\/s42003-021-01873-0.","DOI":"10.1038\/s42003-021-01873-0"},{"issue":"3","key":"1222_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/joe-22-0097","volume":"254","author":"SN Hsu","year":"2022","unstructured":"Hsu SN, Stephen LA, Dillon S, et al. Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy. J Endocrinol. 2022;254(3):153\u201367. https:\/\/doi.org\/10.1530\/joe-22-0097.","journal-title":"J Endocrinol"},{"issue":"2","key":"1222_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/ijms21020385","volume":"21","author":"K Huck","year":"2020","unstructured":"Huck K, Sens C, Wuerfel C, Zoeller C, Nakchbandi A. The Rho GTPase RAC1 in osteoblasts controls their function. IJMS. 2020;21(2):385. https:\/\/doi.org\/10.3390\/ijms21020385.","journal-title":"IJMS"},{"issue":"22","key":"1222_CR13","doi-asserted-by":"publisher","first-page":"8712","DOI":"10.3390\/ijms21228712","volume":"21","author":"KC Hung","year":"2020","unstructured":"Hung KC, Chang JF, Hsu YH, et al. Therapeutic effect of calcimimetics on Osteoclast\u2013Osteoblast crosslink in chronic kidney disease and mineral bone disease. IJMS. 2020;21(22):8712. https:\/\/doi.org\/10.3390\/ijms21228712.","journal-title":"IJMS"},{"issue":"3","key":"1222_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ckj\/sfaa089","volume":"13","author":"K Iseri","year":"2020","unstructured":"Iseri K, Dai L, Chen Z, et al. Bone mineral density and mortality in end-stage renal disease patients. Clin Kidney J. 2020;13(3):307\u201321. https:\/\/doi.org\/10.1093\/ckj\/sfaa089.","journal-title":"Clin Kidney J"},{"issue":"4","key":"1222_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/mnh.0b013e3283546ee0","volume":"21","author":"K Kalantar-Zadeh","year":"2012","unstructured":"Kalantar-Zadeh K, Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S. Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens. 2012;21(4):389\u2013403. https:\/\/doi.org\/10.1097\/mnh.0b013e3283546ee0.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"1222_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2012.01.021","volume":"45","author":"SV Khoronenkova","year":"2012","unstructured":"Khoronenkova SV, Dianova II, Ternette N, Kessler BM, Parsons JL, Dianov GL. ATM-Dependent downregulation of USP7\/HAUSP by PPM1G activates p53 response to DNA damage. Mol Cell. 2012;45(6):801\u201313. https:\/\/doi.org\/10.1016\/j.molcel.2012.01.021.","journal-title":"Mol Cell"},{"key":"1222_CR24","doi-asserted-by":"publisher","unstructured":"Kim JM, Yang YS, Park KH, et al. A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation. Nat Commun. 2020;11(1). https:\/\/doi.org\/10.1038\/s41467-020-16038-6.","DOI":"10.1038\/s41467-020-16038-6"},{"issue":"8","key":"1222_CR20","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41418-022-00952-x","volume":"29","author":"JM Kim","year":"2022","unstructured":"Kim JM, Yang YS, Xie J, et al. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes. Cell Death Differ. 2022a;29(8):1625\u201338. https:\/\/doi.org\/10.1038\/s41418-022-00952-x.","journal-title":"Cell Death Differ"},{"issue":"9","key":"1222_CR57","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.3390\/ijms23095225","volume":"23","author":"K Kim","year":"2022","unstructured":"Kim K, Kim JH, Kim I, et al. Transcription factor Lmx1b negatively regulates osteoblast differentiation and bone formation. IJMS. 2022b;23(9):5225. https:\/\/doi.org\/10.3390\/ijms23095225.","journal-title":"IJMS"},{"issue":"10","key":"1222_CR26","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.3390\/ijms23105776","volume":"23","author":"T Komori","year":"2022","unstructured":"Komori T. Whole aspect of Runx2 functions in skeletal development. IJMS. 2022;23(10):5776. https:\/\/doi.org\/10.3390\/ijms23105776.","journal-title":"IJMS"},{"key":"1222_CR46","doi-asserted-by":"publisher","unstructured":"Li W, Feng W, Su X, et al. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease. J Clin Invest. 2022;132(1). https:\/\/doi.org\/10.1172\/jci150051.","DOI":"10.1172\/jci150051"},{"issue":"3","key":"1222_CR68","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/psp4.12154","volume":"6","author":"A Lisberg","year":"2017","unstructured":"Lisberg A, Ellis R, Nicholson K, et al. Mathematical modeling of the effects of CK2.3 on mineralization in osteoporotic bone. CPT Pharmacometrics Syst Pharmacol. 2017;6(3):208\u201315. https:\/\/doi.org\/10.1002\/psp4.12154.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1222_CR56","doi-asserted-by":"publisher","first-page":"114126","DOI":"10.1016\/j.jep.2021.114126","volume":"275","author":"L Liu","year":"2021","unstructured":"Liu L, Wang L, Li L, et al. Effects of triangle grass Decoction on bone metabolism in rats with chronic kidney disease complicated with mineral and bone abnormalities. J Ethnopharmacol. 2021;275:114126. https:\/\/doi.org\/10.1016\/j.jep.2021.114126.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"1222_CR70","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1177\/00220345221093518","volume":"101","author":"DD Liu","year":"2022","unstructured":"Liu DD, Zhang CY, Liu Y, Li J, Wang YX, Zheng SG. RUNX2 regulates osteoblast differentiation via the BMP4 signaling pathway. J Dent Res. 2022;101(10):1227\u201337. https:\/\/doi.org\/10.1177\/00220345221093518.","journal-title":"J Dent Res"},{"issue":"4","key":"1222_CR31","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/jcmm.16139","volume":"25","author":"X Lu","year":"2021","unstructured":"Lu X, Zhang Y, Zheng Y, Chen B. The miRNA-15b\/USP7\/KDM6B axis engages in the initiation of osteoporosis by modulating osteoblast differentiation and autophagy. J Cell Mol Medi. 2021;25(4):2069\u201381. https:\/\/doi.org\/10.1111\/jcmm.16139.","journal-title":"J Cell Mol Medi"},{"issue":"6","key":"1222_CR37","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/nu15061470","volume":"15","author":"J Mart\u00edn-V\u00edrgala","year":"2023","unstructured":"Mart\u00edn-V\u00edrgala J, Fern\u00e1ndez-Villabrille S, Mart\u00edn-Carro B, et al. Serum and urinary soluble \u03b1-Klotho as markers of kidney and vascular impairment. Nutrients. 2023;15(6):1470. https:\/\/doi.org\/10.3390\/nu15061470.","journal-title":"Nutrients"},{"issue":"7","key":"1222_CR55","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/asn.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification. J Am Soc Nephrol. 2009;20(7):1453\u201364. https:\/\/doi.org\/10.1681\/asn.2008070692.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"1222_CR34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jbmr.4829","volume":"38","author":"FF Mohamed","year":"2023","unstructured":"Mohamed FF, Amadeu de Oliveira F, Kinoshita Y, et al. Dentoalveolar alterations in an Adenine-Induced chronic kidney disease mouse model. J Bone Mineral Res. 2023;38(8):1192\u2013207. https:\/\/doi.org\/10.1002\/jbmr.4829.","journal-title":"J Bone Mineral Res"},{"issue":"2","key":"1222_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ccc.2020.11.013","volume":"37","author":"JA Neyra","year":"2021","unstructured":"Neyra JA, Chawla LS. Acute kidney disease to chronic kidney disease. Crit Care Clin. 2021;37(2):453\u201374. https:\/\/doi.org\/10.1016\/j.ccc.2020.11.013.","journal-title":"Crit Care Clin"},{"issue":"9","key":"1222_CR53","doi-asserted-by":"publisher","first-page":"e108294","DOI":"10.1371\/journal.pone.0108294","volume":"9","author":"H Okura","year":"2014","unstructured":"Okura H, Sato S, Kishikawa S, et al. Runx2-I isoform contributes to fetal bone formation even in the absence of specific N-Terminal amino acids. PLoS ONE. 2014;9(9):e108294. https:\/\/doi.org\/10.1371\/journal.pone.0108294.","journal-title":"PLoS ONE"},{"issue":"4","key":"1222_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/j.ajkd.2020.12.024","volume":"78","author":"M Pazianas","year":"2021","unstructured":"Pazianas M, Miller PD. Osteoporosis and chronic kidney Disease\u2013Mineral and bone disorder (CKD-MBD): back to basics. Am J Kidney Dis. 2021;78(4):582\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2020.12.024.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1222_CR64","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1359\/jbmr.060109","volume":"21","author":"M Phimphilai","year":"2006","unstructured":"Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT. BMP signaling is required for RUNX2-Dependent induction of the osteoblast phenotype. J Bone Miner Res. 2006;21(4):637\u201346. https:\/\/doi.org\/10.1359\/jbmr.060109.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1222_CR5","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/nu13062065","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, Rokicki R, Gluba-Brz\u00f3zka A. The influence of dietary interventions on chronic kidney Disease\u2013Mineral and bone disorder (CKD-MBD). Nutrients. 2021;13(6):2065. https:\/\/doi.org\/10.3390\/nu13062065.","journal-title":"Nutrients"},{"issue":"3","key":"1222_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/tp.0000000000000903","volume":"100","author":"ME Seifert","year":"2016","unstructured":"Seifert ME, Hruska KA. The kidney-Vascular-Bone Axis in the chronic kidney Disease-Mineral bone disorder. Transplantation. 2016;100(3):497\u2013505. https:\/\/doi.org\/10.1097\/tp.0000000000000903.","journal-title":"Transplantation"},{"issue":"14","key":"1222_CR23","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.3390\/ijms21144874","volume":"21","author":"L Sequeira","year":"2020","unstructured":"Sequeira L, Nguyen J, Wang L, Nohe AA, Novel Peptide. CK2.3, improved bone formation in ovariectomized Sprague Dawley rats. IJMS. 2020;21(14):4874. https:\/\/doi.org\/10.3390\/ijms21144874.","journal-title":"IJMS"},{"key":"1222_CR36","doi-asserted-by":"publisher","first-page":"116590","DOI":"10.1016\/j.jep.2023.116590","volume":"314","author":"J Shen","year":"2023","unstructured":"Shen J, Liu Y, Wang Q, et al. Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG\/AMPK signaling pathway. J Ethnopharmacol. 2023;314:116590. https:\/\/doi.org\/10.1016\/j.jep.2023.116590.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"1222_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.nut.2007.06.013","volume":"23","author":"E Son","year":"2007","unstructured":"Son E, Do H, Joo HM, Pyo S. Induction of alkaline phosphatase activity by l-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros. Nutrition. 2007;23(10):745\u201353. https:\/\/doi.org\/10.1016\/j.nut.2007.06.013.","journal-title":"Nutrition"},{"issue":"17","key":"1222_CR43","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/jcmm.17870","volume":"27","author":"X Song","year":"2023","unstructured":"Song X, Dong C, Man X. Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein abundance. J Cell Mol Medi. 2023;27(17):2583\u201393. https:\/\/doi.org\/10.1111\/jcmm.17870.","journal-title":"J Cell Mol Medi"},{"issue":"9","key":"1222_CR51","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/ijms19092490","volume":"19","author":"T Sugatani","year":"2018","unstructured":"Sugatani T. Systemic activation of activin A signaling causes chronic kidney Disease-Mineral bone disorder. IJMS. 2018;19(9):2490. https:\/\/doi.org\/10.3390\/ijms19092490.","journal-title":"IJMS"},{"key":"1222_CR61","doi-asserted-by":"publisher","unstructured":"Tang Y, Lv L, Li W, et al. Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells. Stem Cell Res Ther. 2017;8(1). https:\/\/doi.org\/10.1186\/s13287-017-0637-8.","DOI":"10.1186\/s13287-017-0637-8"},{"issue":"2","key":"1222_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.kint.2020.02.040","volume":"98","author":"Y Tsuboi","year":"2020","unstructured":"Tsuboi Y, Ohtomo S, Ichida Y, et al. EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease\u2013mineral bone disorder. Kidney Int. 2020;98(2):343\u201354. https:\/\/doi.org\/10.1016\/j.kint.2020.02.040.","journal-title":"Kidney Int"},{"issue":"7","key":"1222_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/nano8070513","volume":"8","author":"V Vrathasha","year":"2018","unstructured":"Vrathasha V, Booksh K, Duncan RL, Nohe A. Mechanisms of cellular internalization of quantum Dot\u00ae conjugated bone formation mimetic peptide CK2.3. Nanomaterials. 2018;8(7):513. https:\/\/doi.org\/10.3390\/nano8070513.","journal-title":"Nanomaterials"},{"issue":"1","key":"1222_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/os.12087","volume":"6","author":"W Wang","year":"2014","unstructured":"Wang W, Sun C, Liu Z, et al. Transcription factor Runx2 in the low bone mineral density of girls with adolescent idiopathic scoliosis. Orthop Surg. 2014;6(1):8\u201314. https:\/\/doi.org\/10.1111\/os.12087.","journal-title":"Orthop Surg"},{"key":"1222_CR59","doi-asserted-by":"publisher","unstructured":"Wang Z, Kang W, You Y, et al. USP7: novel drug target in Cancer therapy. Front Pharmacol. 2019;10. https:\/\/doi.org\/10.3389\/fphar.2019.00427.","DOI":"10.3389\/fphar.2019.00427"},{"issue":"1","key":"1222_CR1","doi-asserted-by":"publisher","first-page":"s31","DOI":"10.1590\/1806-9282.66.s1.31","volume":"66","author":"R Watanabe","year":"2020","unstructured":"Watanabe R. Hyperkalemia in chronic kidney disease. Rev Assoc Med Bras. 2020;66(1):s31\u20136. https:\/\/doi.org\/10.1590\/1806-9282.66.s1.31.","journal-title":"Rev Assoc Med Bras"},{"issue":"23","key":"1222_CR69","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.3390\/ijms20235877","volume":"20","author":"H Weidner","year":"2019","unstructured":"Weidner H, Yuan Gao V, Dibert D, et al. CK2.3, a mimetic peptide of the BMP type I receptor, increases activity in osteoblasts over BMP2. IJMS. 2019;20(23):5877. https:\/\/doi.org\/10.3390\/ijms20235877.","journal-title":"IJMS"},{"issue":"1","key":"1222_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","volume":"93","author":"MJ Williams","year":"2018","unstructured":"Williams MJ, Sugatani T, Agapova OA, et al. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int. 2018;93(1):147\u201358. https:\/\/doi.org\/10.1016\/j.kint.2017.06.016.","journal-title":"Kidney Int"},{"issue":"7","key":"1222_CR32","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cmet.2022.05.010","volume":"34","author":"H Wu","year":"2022","unstructured":"Wu H, Gonzalez Villalobos R, Yao X, et al. Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies. Cell Metabol. 2022;34(7):1064\u2013e10786. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.010.","journal-title":"Cell Metabol"},{"issue":"19","key":"1222_CR52","doi-asserted-by":"publisher","first-page":"20307","DOI":"10.1074\/jbc.m401109200","volume":"279","author":"ZS Xiao","year":"2004","unstructured":"Xiao ZS, Hjelmeland AB, Quarles LD. Selective deficiency of the Bone-related Runx2-II unexpectedly preserves Osteoblast-mediated skeletogenesis. J Biol Chem. 2004;279(19):20307\u201313. https:\/\/doi.org\/10.1074\/jbc.m401109200.","journal-title":"J Biol Chem"},{"issue":"2","key":"1222_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ydbio.2005.04.028","volume":"283","author":"Z Xiao","year":"2005","unstructured":"Xiao Z, Awad HA, Liu S, et al. Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev Biol. 2005;283(2):345\u201356. https:\/\/doi.org\/10.1016\/j.ydbio.2005.04.028.","journal-title":"Dev Biol"},{"key":"1222_CR50","doi-asserted-by":"publisher","first-page":"117518","DOI":"10.1016\/j.cca.2023.117518","volume":"548","author":"D Xie","year":"2023","unstructured":"Xie D, Zhao L, Wu L, Ji Q. The levels of bone turnover markers and parathyroid hormone and their relationship in chronic kidney disease. Clin Chim Acta. 2023;548:117518. https:\/\/doi.org\/10.1016\/j.cca.2023.117518.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1222_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-020-00666-7","volume":"106","author":"Y Xin","year":"2020","unstructured":"Xin Y, Liu Y, Liu D, et al. New function of RUNX2 in regulating osteoclast differentiation via the AKT\/NFATc1\/CTSK Axis. Calcif Tissue Int. 2020;106(5):553\u201366. https:\/\/doi.org\/10.1007\/s00223-020-00666-7.","journal-title":"Calcif Tissue Int"},{"issue":"17","key":"1222_CR11","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"H Yanai","year":"2021","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical Understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. IJMS. 2021;22(17):9221. https:\/\/doi.org\/10.3390\/ijms22179221.","journal-title":"IJMS"},{"issue":"2","key":"1222_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/circresaha.121.319745","volume":"130","author":"L Yang","year":"2022","unstructured":"Yang L, Dai R, Wu H, et al. Unspliced XBP1 counteracts \u03b2-Catenin to inhibit vascular calcification. Circul Res. 2022;130(2):213\u201329. https:\/\/doi.org\/10.1161\/circresaha.121.319745.","journal-title":"Circul Res"},{"issue":"6","key":"1222_CR33","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.3390\/ijms24065325","volume":"24","author":"A Zaloszyc","year":"2023","unstructured":"Zaloszyc A, Bernardor J, Bacchetta J, Laverny G, Schmitt CP. Mouse models of mineral bone disorders associated with chronic kidney disease. IJMS. 2023;24(6):5325. https:\/\/doi.org\/10.3390\/ijms24065325.","journal-title":"IJMS"},{"key":"1222_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2909454","volume":"2021","author":"H Zhu","year":"2021","unstructured":"Zhu H, Chen H, Ding D, Wang S, Dai X, Zhu Y. Overexpression of PIK3R1 promotes bone formation by regulating osteoblast differentiation and osteoclast formation. Comput Math Methods Med. 2021;2021:1\u201313. https:\/\/doi.org\/10.1155\/2021\/2909454.","journal-title":"Comput Math Methods Med"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:13:57Z","timestamp":1748603637000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1222"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01222-5","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University under approval number 2021-311. The study does not involve clinical tissue experiments, and hence no clinical ethics approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}